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OBJECTIVE: To investigate the relation between major depressive disorder and metabolic risk factors of coronary
heart disease.
INTRODUCTION: Little evidence is available indicating a relationship between major depressive disorder and
metabolic risk factors of coronary heart disease such as lipoprotein and apolipoprotein.
METHODS: This case–control study included 153 patients with major depressive disorder who fulfilled the criteria of
the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV), and 147 healthy individuals. All
participants completed a demographic questionnaire and Hamilton rating scale for depression. Anthropometric
characteristics were recorded. Blood samples were taken and total cholesterol, high- and low-density lipoproteins
and apolipoproteins A and B were measured. To analyze the data, t-test, x2 test, Pearson correlation test and linear
regression were applied.
RESULTS: Depression was a negative predictor of apolipoprotein A (b=20.328, p,0.01) and positive predictor of
apolipoprotein B (b=0.290, p,0.05). Apolipoprotein A was inversely predicted by total cholesterol (b=20.269,
p,0.05) and positively predicted by high-density lipoprotein (b=0.401, p,0.01). Also, low-density lipoprotein was a
predictor of apolipoprotein B (b=0.340, p,0.01). The severity of depression was correlated with the increment in
serum apolipoprotein B levels and the decrement in serum apolipoprotein A level.
CONCLUSION: In view of the relationship between apolipoproteins A and B and depression, it would seem that
screening of these metabolic risk factors besides psychological interventions is necessary in depressed patients.
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INTRODUCTION
Major depressive disorder (MDD) is the most common
mood disorder with a significant effect on the progression of
medical conditions.1 Factors accompanying depression,
such as patients’ failure to look after their health, inability
to adapt to their environment, social dissociation, chronic
stresses of life, cigarette smoking, reduced physical activity,
inappropriate nutrition and poor compliance with medical
advice, make depression one of the risk factors of non-
communicable diseases.2
In addition to the effect of depression on lifestyle, the
direct effect of depression on metabolic factors has been
shown in many studies.3 Recently, a relationship has been
observed between depression and serum levels of lipopro-
teins and apolipoproteins (apo), which are known risk
factors of obesity and cardiovascular diseases.4 One theory
of this relationship suggests a disturbance in function of the
serotonergic system. In addition, metabolic changes in
patients with MDD are due to genetic changes in the coding
of serum lipoproteins.5 Other theories describe changes in
interleukin 2, number of total T-cells, melatonin and other
cytokines in depressed patients.6-8
Despite these studies, controversy exists about the rela-
tionship between depression and the lipid profile. Studies
have shown different results for the level of apo A—one of
the high-density lipoprotein cholesterol (HDL-C) sub-
groups, and of apo B—the major protein of low-density
lipoprotein cholesterol (LDL-C), in patients with MDD.4,9,10
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Sevincok and Sarandol showed that the serum level of
apo A in depressed patients was lower than that in control
group.4,9 Another study showed no significant difference in
the serum levels of apolipoproteins between depressed
patients and the control group.11
The lack of evidence and controversial results of previous
studies led us design this study to compare the serum levels
of apolipoproteins in depressed patients and normal
individuals.
METHODS
A population of 153 patients with MDD (63 women, 90
men, aged 21–47 years) in 2007 were included in this case–
control study. All the patients were diagnosed with MDD
according to the Structured Clinical Interview (SCID-I) for
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV). Relatives of hospitalized patients
and hospital university staff comprised the control group
(78 women, 69 men, aged 18–47 years).
Exclusion Criteria
Patients with an axis I or II disorder in addition to their
depression, patients with MDD with psychotic features,
bipolar disorder, cyclothymia, dysthymia, anxiety disorder
and patients at significant risk of suicide were excluded
from the study via the structured clinical interview for
DSM-IV.
Exclusion criteria for both case and control groups
included the presence of organic diseases such as hyperten-
sion, diabetes, cardiovascular, adrenal, hepatic and thyroid
diseases documented by physical examination and labora-
tory tests; history of anti-lipid and b-blocker consumption;
and menopause in women.
Laboratory tests, including complete blood count, serum
electrolyte assay, liver function tests, thyroid function tests,
urine analyses and electrocardiography, were performed for
all participants to screen for major health problems. In
addition, after explanation of the study, informed consent
was obtained from all participants. The study protocol was
approved by the ethical committee of the Isfahan University
of Medical Sciences.
Measurements
All participants completed a self-administered question-
naire to determine demographic characteristics such as age,
gender, socioeconomic status (occupation, marital status
and educational level), smoking status, drug history, family
history of depression, physical activity and diet. Subjects
were considered to be ‘‘current smokers’’ if they reported
smoking at least one cigarette a day during the past year.
Anthropometric characteristics (height and weight) were
measured with the subjects wearing thin clothes. Body mass
index (BMI) was calculated by dividing a participant’s
weight by their height squared (kg/m2). Regular physical
activity was defined as exercise of at least 15 minutes’
duration at least twice each week.13
Participants provided details of their dietary habits by
completing a Food Frequency Questionnaire (FFQ).14 This
instrument was designed according to the WHO-FFQ, with
some changes. The validity of this questionnaire was
confirmed before its use by the Medical Education
Development Center affiliated to Isfahan University of
Medical Sciences.15 The FFQ was used to access the
consumption of different food groups such as meat, oils,
cereals, vegetables and fruits.
Eligible participants also completed a 17-item Hamilton
rating scale for Depression (HAM-D), which is the most
commonly used observer-rated depressive symptom rating
scale. The original scale has 21 items but, as Hamilton has
suggested, only the initial 17 items were scored in this study
because the last 4 items rarely occur and deal only with
aspects of illness. Items with quantifiable severity were
ranked on a scale of 0–4 and those measuring symptoms that
are difficult to assess reliably were ranked on a scale of 0–2.
The range of the 17-item scale was 0–50, with 14 considered to
be the cut-off point of this scale; higher scores indicated more
severe depression. According to HAM-D, patients were
classified into 3 groups of mild MDD (score 15–18), moderate
MDD (score 19–22) and severe MDD (score $23).16,17
A blood sample was taken after 12–14 hours’ fasting
through the antecubital vein. All the blood sampling
procedures were performed in the central laboratory of
the Isfahan Cardiovascular Research Centre. Serum trigly-
ceride (TG), total cholesterol (TC), HDL-C, LDL-C and apo
A and B were measured for each patient. TC and TG levels
were measured within 24 h by an enzymatic method using
an Elan 2000 autoanalyze. HDL-C was assayed by the direct
method. LDL-C was calculated by the Friedewald for-
mula,18 but in cases with TG$400 mg/dl, it was measured
directly. Apo A and B were measured by immunoturbidi-
metry using Pars Azmoon kits accredited by Bioactiva
Diagnostica (Germany).
Statistical Analysis
Continuous variables were expressed as mean ¡ SD and
a t-test was used to compare the means between the two
groups. Qualitative variables were expressed as frequency
and a x2 test used to compare frequencies between the two
groups.
A Pearson correlation test was used to evaluate the
correlation of depression with apo A and apo B. To study
the association of depression and apo A and B (apo A and B,
separately), multiple linear regression models were used.
Apo A and B were entered as dependent variables, and the
group (case vs. control), smoking status (smokers vs. non-
smokers), BMI, TC, LDL-C and HDL-C were entered as
independent variables. The enter approach was selected for
regression model, and for each apo A and B a unique model
was created. The presumption of a linear regression model
was used for both models.
Data were analyzed by SPSS version 15.0 (SPSS Inc,
Chicago, Illinois, USA). A p-value ,0.05 was considered
significant.
RESULTS
Table 1 showed the baseline characteristics of partici-
pants. The baseline variables sex, age, marital state and
occupation were similar in case and control groups. The
mean age of participants was 31.21¡10.41 years in the
group with MDD vs. 32.00¡8.21 years in the control group.
Depressed patients were significantly more likely to have a
family history of depression and a past history of smoking
(p,0.05).
The duration of depression was 4.07¡1.84 years in pati-
ents. Fifty-four patients were mildly depressed (35.3%), 69
were moderately depressed (45.1%) and 30 were severely
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depressed (19.6%). There were no statistically significant
differences between the two groups in BMI and physical
activity. Consumption of different groups of foods, which
was assessed by the FFQ, showed no significant statistical
difference between the two groups.
Concentrations of all serum lipids and apo A and B
differed significantly between the two groups. TC, LDL-C
and apo B were higher, while HDL-C and apo A were
lower, in the case group than in controls (Table 1).
Linear regression analysis showed that serum apo A
levels were negatively (p,0.01) and serum apo B levels
were positively (p,0.05) predicted by depression. Serum
TC levels predicted negatively (p,0.05) and HDL-C
levels predicted positively (p,0.01) the serum apo A levels.
LDL-C levels predicted positively the serum apo B levels
(p,0.01). Smoking status and BMI did not significantly
predict the apo A and B levels (Table 2).
The correlation between depression severity according to
HAM-D and serum levels of the apolipoproteins indicated
an inverse relationship between depression severity and
serum apo A levels (r =20.453, p,0.01) and a direct
relationship between depression severity and serum apo B
levels (r = 0.521, p,0.05).
DISCUSSION
Our findings showed a significant correlation between
serum levels of apolipoproteins and depression so that the
Table 1 - Basic characteristics of case (n= 153) and control (n =147) groups.
MDD group (N=153) Control group (N=147) p-Value{
Characteristics Mean¡SD Mean¡SD
Age (years) 31.21¡10.41 32.00¡8.21 NS*
Body mass index (kg/m2) 22.06¡3.23 21.50¡3.01 NS
Cholesterol (mg/dl) 158.03¡27.69 136.59¡28.59 0.06
Low-density lipoprotein (mg/dl) 92.96¡20.74 79.59¡21.31 0.01
High-density lipoprotein (mg/dl) 35.96¡7.39 44.65¡8.26 0.03
Apolipoprotein A (mg/dl) 130.78¡24.44 151.09¡34.20 #0.001
Apolipoprotein B (mg/dl) 91.78¡26.54 85.71¡25.82 0.05
Hamilton Depression Rating Scale 20.8¡10.07 3.96¡1.73 #0.001
N % N % p-Value{
Sex NS
Men 90 58.8 69 46.9
Women 63 41.2 78 53.1
Occupation NS
Unemployed 54 35.3 51 34.7
Home worker 33 21.6 39 26.5
Salary employed 42 27.5 42 28.6
Self-employed 24 15.7 15 10.2
Marital status NS
Married 87 56.9 90 61.2
Unmarried(single, widow, divorced) 66 43.1 57 38.8
Educational level NS
0-5 years 54 35.3 51 34.7
6-12 years 45 29.4 39 26.5
.12 years 54 35.3 57 38.8
Positive family history 0.04
Yes 30 19.6 6 4.1
No 123
Smoking 0.02
Yes 60 39.3 24 16.3
No 93 60.7 123 83.7
*NS, not significant.
{p-Values were based on t-test.
{p-Values were based on x2 test.
Table 2 - Predictors of serum apolipoprotein A and apolipoprotein B levels.
Apolipoprotein A Apolipoprotein B
Variables Standardized b p-Value Standardized b p-Value
Group* 20.328 0.008 0.290 0.022
Smoking status{ 0.137 0.248 20.099 0.479
Body mass index (kg/m2) 0.074 0.543 0.101 0.453
Total cholesterol (mg/dl) 20.269 0.044 0.066 0.687
Low-density lipoprotein (mg/dl) 0.159 0.094 0.340 0.006
High-density lipoprotein (mg/dl) 0.401 0.001 20.024 0.854
Adjusted R2 0.227 0.200
*Depressed patient = 1; control = 0.
{Smoker = 1; non-smoker = 0.
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serum level of HDL-C and apo A were lower, while LDL-C
and apo B (atherogenic lipoproteins) were higher, in
patients with MDD than those in the control group. In
addition, severity of depression correlated with an incre-
ment in serum apo B level and a decrement in serum apo A
level.
Only a few studies have investigated the serum apolipo-
protein levels in patients with MDD. Sarandol et al.
investigated the oxidation of apo B-containing lipoproteins
and the serum paraoxonase and arylesterase activities in
MDD. Their case group included patients with MDD who
had not received antidepressant drugs for at least 3 weeks.
Higher TC, HDL-C, LDL-C and apo B, and lower apo A,
levels were found in the case group. The patients were
treated with a standard dosage of antidepressant drugs for 6
weeks, which did not alter the serum levels of lipid
profiles.4 However, there is some evidence that antidepres-
sant agents may affect serum lipid profile levels.9 Thus, we
excluded patients who had taken antidepressant drugs
during the past 6 months. Our results, except those for
HDL-C, were in line with those of Sarandol et al.
Association between serum HDL-C and LDL-C levels as
predictors of coronary heart disease (CHD) and MDD is one
of the fields which has been investigated.19 Few studies
have shown an inverse association between them.2 A meta-
analysis on the association of cholesterol and depression
showed that TC and depression were inversely related.21 On
the other hand, some studies, such as that of Chen et al.,
demonstrated lower HDL-C and higher LDL-C and TC
levels in patients with MDD.22 Similarly, Nakao and Yano
showed significant direct association between hypercholes-
terolemia and patients with MDD in Japanese men.23 Since
apo A is known to be a major fraction of HDL-C and apo B
is known to be a major fraction of LDL-C, our results were
in accordance with the results of these studies.
Depression is associated with CHD—that is, depressed
patients are more prone to develop CHD.24,25 Because of this
association, the relationship between depression and other
risk factors of CHD such as serum apolipoprotein levels is
an important subject that should examined more closely.
There are some biological hypotheses which may explain
this association. One hypothesis suggests that genetic
factors associated with depression may contribute to a
change in serum lipid levels.26 A second theory proposes
that cholesterol may be an important factor in reducing the
possibility of correction of metabolic defects. As a result of
these defects, segmental cerebral hypoxia, which may
associated with depression, could occur.27 Altered lipid
profile levels through changes in serotonergic systems
might also lead to MDD.28
This study has some limitations. Owing to the cross-
sectional design of the study, the cause and effect relationship
and mechanisms of the association between depression and
lipid profile could not be determined. Also, some of our data
were based on self-reported questionnaires, which are less
reliable sources of information than direct measurement.
Also, as previously mentioned, although our case and control
groups had no differences in socioeconomic status, some of
the control group comprised university hospital staff.
CONCLUSION
The results of the study demonstrated lower serum levels
of apo A and HDL-C and higher serum levels of apo B and
LDL-C in depressed patients than in the control group. Thus
in depressed patients, biochemical problems should be
considered and evaluated together with psychological
interventions. Given the relationship between apolipopro-
teins and depression, checking the lipid profile as predicting
factors of CHD to prevent the appearance of extra
cardiovascular risk factors seems necessary.
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